Follow
Wira Winardi
Title
Cited by
Cited by
Year
Coronavirus disease 2019 (COVID-19): A literature review
H Harapan, N Itoh, A Yufika, W Winardi, S Keam, H Te, D Megawati, ...
Journal of infection and public health 13 (5), 667-673, 2020
20632020
Acceptance of a COVID-19 vaccine in Southeast Asia: a cross-sectional study in Indonesia
H Harapan, AL Wagner, A Yufika, W Winardi, S Anwar, AK Gan, ...
Frontiers in public health 8, 381, 2020
7262020
Willingness-to-pay for a COVID-19 vaccine and its associated determinants in Indonesia
H Harapan, AL Wagner, A Yufika, W Winardi, S Anwar, AK Gan, ...
Human vaccines & immunotherapeutics 16 (12), 3074-3080, 2020
1602020
Monkeypox: a comprehensive review
H Harapan, Y Ophinni, D Megawati, A Frediansyah, SS Mamada, ...
Viruses 14 (10), 2155, 2022
742022
Disruption of childhood vaccination during the COVID-19 pandemic in Indonesia
M Fahriani, S Anwar, A Yufika, B Bakhtiar, E Wardani, W Winardi, KB Akel, ...
Narra j 1 (1), 2021
612021
Host genome polymorphisms and tuberculosis infection: What we have to say?
SA Khalilullah, H Harapan, NA Hasan, W Winardi, I Ichsan, M Mulyadi
Egyptian Journal of Chest Diseases and Tuberculosis 63 (1), 173-185, 2014
582014
Stigma associated with COVID-19 among health care workers in Indonesia
A Yufika, R Pratama, S Anwar, W Winardi, N Librianty, NAP Prashanti, ...
Disaster medicine and public health preparedness 16 (5), 1942-1946, 2022
412022
Activation of insulin‐like growth factor‐1 receptor confers acquired resistance to osimertinib in non‐small cell lung cancer with EGFR T790M mutation
D Hayakawa, F Takahashi, Y Mitsuishi, K Tajima, M Hidayat, W Winardi, ...
Thoracic cancer 11 (1), 140-149, 2020
402020
The use of indoor plant as an alternative strategy to improve indoor air quality in Indonesia
AD Susanto, W Winardi, M Hidayat, A Wirawan
Reviews on Environmental health 36 (1), 95-99, 2021
292021
Perceived risk of being infected with SARS-CoV-2: A perspective from Indonesia
H Harapan, S Anwar, F Nainu, AM Setiawan, A Yufika, W Winardi, AK Gan, ...
Disaster medicine and public health preparedness 16 (2), 455-459, 2022
252022
Knowledge of coronavirus disease 2019 (COVID-19) among healthcare providers: A cross-sectional study in Indonesia
KF Jamil, W Winardi, A Yufika, S Anwar, N Librianty, NAP Prashanti, ...
Asian Pacific Journal of Tropical Medicine 13 (9), 402-408, 2020
212020
Nintedanib inhibits epithelial-mesenchymal transition in A549 alveolar epithelial cells through regulation of the TGF-β/Smad pathway
H Ihara, Y Mitsuishi, M Kato, F Takahashi, K Tajima, T Hayashi, M Hidayat, ...
Respiratory Investigation 58 (4), 275-284, 2020
192020
Role of FBXW7 in the quiescence of gefitinib-resistant lung cancer stem cells in EGFR-mutant non-small cell lung cancer
M Hidayat, Y Mitsuishi, F Takahashi, K Tajima, T Yae, K Miyahara, ...
Bosnian journal of basic medical sciences 19 (4), 355, 2019
172019
Genetic polymorphisms of HLA and HLA-related proteins: Implications on dengue virus infection
H Harapan, JK Fajar, SA Khalilullah, W Winardi, KF Jamil
Journal of Mosquito Research 3 (1), 1-10, 2013
112013
Challenges on tuberculosis care in health care facilities during COVID-19 pandemic: Indonesian perspective
W Winardi, H Wahyuni, M Hidayat, A Wirawan, F Nurwidya, MN Uddin, ...
Narra J 2 (2), 2022
92022
Monkeypox: A Comprehensive Review. Viruses 2022, 14, 2155
H Harapan, Y Ophinni, D Megawati, A Frediansyah, SS Mamada, ...
s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022
82022
A novel therapeutic strategy targeting the mesenchymal phenotype of malignant pleural mesothelioma by suppressing LSD1
A Wirawan, K Tajima, F Takahashi, Y Mitsuishi, W Winardi, M Hidayat, ...
Molecular Cancer Research 20 (1), 127-138, 2022
82022
Zinc‐finger E‐box‐binding homeobox 1 (ZEB1) plays a crucial role in the maintenance of lung cancer stem cells resistant to gefitinib
F Nurwidya, F Takahashi, W Winardi, K Tajima, Y Mitsuishi, A Murakami, ...
Thoracic Cancer 12 (10), 1536-1548, 2021
72021
Willingness to pay (WTP) for COVID-19 vaccine booster dose and its determinants in Indonesia
H Harapan, M Sallam, R Fathima, HI Kusuma, S Anwar, WY Nalapraya, ...
Infectious disease reports 14 (6), 1017-1032, 2022
52022
Drivers of and barriers to COVID-19 vaccine booster dose acceptance in Indonesia
H Harapan, R Fathima, HI Kusuma, S Anwar, WY Nalapraya, A Wibowo, ...
Vaccines 10 (12), 1981, 2022
42022
The system can't perform the operation now. Try again later.
Articles 1–20